Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.32 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | GMNN | O75496 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 2/20 | 0.32 |
| ▸ | CA2 | P00918 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | BLM | P54132 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | SGMS1 | Q86VZ5 | 1/20 | 0.32 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.32 |
| ▸ | CTDSP1 | Q9GZU7 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18683555 | 1.00 | MAPT (0.32) | MAPTCA12GMNNALDH1A1CA1 | |
| SCHEMBL18391716 | 1.00 | MAPT (0.32) | MAPTCA12GMNNALDH1A1CA1 | |
| SCHEMBL28257150 | 1.00 | MAPT (0.32) | MAPTCA12GMNNALDH1A1CA1 | |
| SCHEMBL25688662 | 1.00 | MAPT (0.32) | MAPTCA12GMNNALDH1A1CA1 | |
| SCHEMBL4544647 | 1.00 | MAPT (0.32) | MAPTCA12GMNNALDH1A1CA1 | |
| SCHEMBL17538638 | 1.00 | MAPT (0.32) | MAPTCA12GMNNALDH1A1CA1 | |
| SCHEMBL18683565 | 1.00 | MAPT (0.32) | MAPTCA12GMNNALDH1A1CA1 | |
| SCHEMBL30156363 | 0.95 | TSHR (0.33) | MAPTCA12GMNNALDH1A1CA1 | |
| SCHEMBL16207199 | 0.93 | TSHR (0.35) | ALDH1A1TSHR | |
| Ethylene Glycol SCHEMBL28177955 | 0.92 | CYP1A2 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250000086-A1 | NEW MICROPARTICLES CONTAINING ACTIVE SUBSTANCES | BASF SE (DE) | 2025-01-02 | — | — | US | disclosed |
| EP-4398886-A1 | NEW MICROPARTICLES CONTAINING ACTIVE SUBSTANCES | BASF SE (DE) | 2024-07-17 | — | — | EP | disclosed |
| US-20240172746-A1 | NEW MICROPARTICLES CONTAINING ACTIVE SUBSTANCES | BASF SE (DE) | 2024-05-30 | — | — | US | disclosed |
| EP-4304354-A1 | NEW MICROPARTICLES CONTAINING ACTIVE SUBSTANCES | BASF SE (DE) | 2024-01-17 | — | — | EP | disclosed |
| WO-2023036636-A1 | NEW MICROPARTICLES CONTAINING ACTIVE SUBSTANCES | BASF SE (DE) | 2023-03-16 | — | — | WO | disclosed |
| WO-2022189208-A1 | NEW MICROPARTICLES CONTAINING ACTIVE SUBSTANCES | BASF SE (DE) | 2022-09-15 | — | — | WO | disclosed |
| EP-4056038-A1 | MICROPARTICLES CONTAINING ACTIVE SUBSTANCES | BASF SE (DE) | 2022-09-14 | — | — | EP | disclosed |
| EP-0063368-A1 | Process for the preparation of pregn-4-ene-3,20-dione derivatives and 17-alpha-ethynyl-17-beta-trifluoroacetoxy-gon-4-ene-3-one derivatives, and pharmaceutical compositions containing the latter compounds | RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) | 1982-10-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240172746-A1 | NEW MICROPARTICLES CONTAINING ACTIVE SUBSTANCES | SGMS1, SGMS2, LIPA | MAPT 1924/4885CA12 3121/4885GMNN 4493/4885 |
| US-20250000086-A1 | NEW MICROPARTICLES CONTAINING ACTIVE SUBSTANCES | SGMS1, PTDSS1, PLA2G2C | MAPT 2290/4885CA12 1032/4885GMNN 4528/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.